Journal article
Fragment-based and structure-guided discovery of perforin inhibitors
J Jose, RHP Law, EWW Leung, DCC Wai, H Akhlaghi, IR Chandrashekaran, TT Caradoc-Davies, I Voskoboinik, J Feutrill, D Middlemiss, D Jeevarajah, T Bashtannyk-Puhalovich, AC Giddens, TW Lee, SMF Jamieson, JA Trapani, JC Whisstock, JA Spicer, RS Norton
European Journal of Medicinal Chemistry | Published : 2023
Open access
Abstract
Perforin is a pore-forming protein whose normal function enables cytotoxic T and natural killer (NK) cells to kill virus-infected and transformed cells. Conversely, unwanted perforin activity can also result in auto-immune attack, graft rejection and aberrant responses to pathogens. Perforin is critical for the function of the granule exocytosis cell death pathway and is therefore a target for drug development. In this study, by screening a fragment library using NMR and surface plasmon resonance, we identified 4,4-diaminodiphenyl sulfone (dapsone) as a perforin ligand. We also found that dapsone has modest (mM) inhibitory activity of perforin lytic activity in a red blood cell lysis assay i..
View full abstractGrants
Awarded by Wellcome Trust
Funding Acknowledgements
This study was supported by the Australian National Health Medical Research Council (NHMRC) (Grant 1100478) and a Wellcome Trust Seeding Drug Discovery Award (Grant 092717) . R.S.N. and J.C.W. acknowledge fellowship support from the National Health and Medical Research Council of Australia. J.A.S. acknowledges fellowship support from Cancer Society Auckland Northland and funding from the University of Auckland Faculty Research Development Fund.